Role of cyclooxygenase inhibitors for the prevention of colorectal cancer

E Stack, RN DuBois - Gastroenterology Clinics, 2001 - gastro.theclinics.com
Arachidonic acid is distributed throughout the lipid bilayer of mammalian cells and normally
is esterified to phospholipid. Most arachidonic acid comes directly from the diet or through …

New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity

RA Gupta, RN DuBois, MC Wallace - Best Practice & Research Clinical …, 2002 - Elsevier
Carcinoma of the colon and/or rectum represents the second most common gastrointestinal
malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely …

Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side

S Samoha, N Arber - Oncology, 2005 - karger.com
Cancer is predicted to become the leading cause of death–surpassing heart disease–by the
end of this decade. Colorectal cancer is a major health concern, with more than 1,000,000 …

Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point

N Arber - Cancer Epidemiology Biomarkers & Prevention, 2008 - AACR
The limited success of current treatments for most advanced common malignancies
highlights the importance of cancer prevention. Clinical trials on cyclooxygenase (COX) …

Cyclooxygenase-2 and colorectal cancer

RN DuBois - COX-2, 2003 - karger.com
Colorectal cancer (CRC) leads to approximately 550,000 annual deaths worldwide and is
thus a major public health concern [1]. Once an individual is diagnosed with CRC, the …

Cyclooxygenase-2 inhibitors in colorectal cancer

J Stoehlmacher, HJ Lenz - Seminars in oncology, 2003 - Elsevier
Cyclooxygenase (COX) enzyme-dependent arachidonic acid metabolites occupy key
positions in important physiologic processes such as immunity, reproduction, and vascular …

Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer

E Hahn, S Kraus, N Arber - Digestive Diseases, 2010 - karger.com
Chemoprevention of colorectal cancer is a promising science that has particular importance
due to the limited success of current treatments for most advanced common malignancies …

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2

RA Gupta, RN DuBois - Nature Reviews Cancer, 2001 - nature.com
Population-based studies have established that long-term intake of non-steroidal anti-
inflammatory drugs (NSAIDs), compounds that inhibit the enzymatic activity of …

cyclooxygenase–a target for colon cancer prevention

RN Dubois - Alimentary Pharmacology & Therapeutics, 2000 - Wiley Online Library
Use of nonsteroidal anti‐inflammatory drugs such as aspirin, which are known to inhibit
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40–50 …

Reducing the risk of colorectal cancer by intervening in the process of carcinogenesis: a status report

DS Alberts - The Cancer Journal, 2002 - journals.lww.com
Risk factors for colorectal cancer have been identified, and significant advances have been
made in understanding the process of colorectal carcinogenesis. The transition from normal …